Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication ...

I've been trying to come up with a pitch for an apolitical music column to run during election week. Why not revisit 2020?

Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

Novo Nordisk says Wegovy can help heart disease ... Its injectable counterpart, Ozempic, in 2020 won an FDA approval to reduce the risk of cardiovascular-related events in Type 2 diabetes patients ...

Fisher Asset Management's portfolio value increased to $244B, with top holdings in Apple, Microsoft, Nvidia, Amazon, and ...

The Arkansas Republican, who could be the next chairman of the top banking panel in the House, could find some areas of ...

It is always worth paying attention when someone wins a Nobel Prize for their life’s work, but a couple of awards this year ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...